This is a special purpose acquisition company (SPAC) that raised $230M in its IPO in February 2026, with the proceeds held in a Trust Account. The company has no operating business — its sole purpose is to identify and acquire a private company, taking it public through a Business Combination, which must be completed by February 2028 or the Trust Account is returned to public shareholders. The management team, led by CEO Brent Michael Cox and CFO Anthony Michael Naimo under the sponsorship of Cambridge Sponsor LLC, focuses on "high-growth, recession-resilient" consumer categories including nicotine harm reduction, hemp-derived consumables, psychedelics, functional botanicals, gaming, and what the team calls the "love economy." The sponsor acquired Founder Shares at nominal cost, which convert into roughly 25% of the post-combination company upon deal close — a structure that strongly incentivizes sponsors to complete a deal, since failure means forfeiting that stake entirely. After deferred underwriting fees, approximately $222M from the Trust Account is available to fund a Business Combination, assuming no shareholder redemptions. Public shareholders can redeem shares at roughly $10.00 per share plus accrued interest if they dislike the chosen target or if no deal is completed.